HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Turner, S. J. Articles by Ruby, J. Search for Related Content PubMed PubMed Citation Articles by Turner, S. J. Articles by Ruby, J. Agricola Articles by Turner, S. J. Articles by Ruby, J.

Characterization of the ectromelia virus serpin, SPI-2

Department of Microbiology and Immunology, University of Melbourne, Parkville 3010, Australia¹
The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Melbourne 3050, Australia²

Author for correspondence: Janet Ruby. Fax +61 3 9347 1540. e-mail j.ruby{at}microbiology.unimelb.edu.au

Poxviruses encode multiple proteins that enable them to evade host responses. Among these are serine protease inhibitors (serpins). One of the earliest serpins described, cowpox virus crmA, acts to inhibit inflammation and apoptosis. crmA homologous serpins, known as SPI-2, are conserved in rabbitpox, vaccinia and variola viruses. Here, we describe the characterization of ectromelia virus (EV) SPI-2. EV SPI-2 encodes a protein of approximately 38 kDa showing >94% identity with other poxviral homologues. Conservative changes in amino acid sequence were found within the reactive site loop and the serpin backbone. Like crmA, transient expression of SPI-2 protected cells from tumour necrosis factor-mediated apoptosis and inhibited the activity of caspases-1 and -8 but not caspases-3, -6 or granzyme B. Overall, this study demonstrates that EV SPI-2 is functionally similar to crmA, based on in vitro assays.

This article has been cited by other articles:

				M. Bots and J. P. Medema Serpins in T cell immunity J. Leukoc. Biol., November 1, 2008; 84(5): 1238 - 1247. [Abstract] [Full Text] [PDF]

				B. Bade, H. E. Boettcher, J. Lohrmann, C. Hink-Schauer, K. Bratke, D. E. Jenne, J. C. Virchow Jr, and W. Luttmann Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes Int. Immunol., November 1, 2005; 17(11): 1419 - 1428. [Abstract] [Full Text] [PDF]

				D. J. Esteban and R. M. L. Buller Ectromelia virus: the causative agent of mousepox J. Gen. Virol., October 1, 2005; 86(10): 2645 - 2659. [Abstract] [Full Text] [PDF]

				M. Krzyzowska, M. Polanczyk, M. Bas, J. Cymerys, A. Schollenberger, F. Chiodi, and M. Niemialtowski Mousepox conjunctivitis: the role of Fas/FasL-mediated apoptosis of epithelial cells in virus dissemination J. Gen. Virol., July 1, 2005; 86(7): 2007 - 2018. [Abstract] [Full Text] [PDF]

				M. Saraiva, P. Smith, P. G. Fallon, and A. Alcami Inhibition of Type 1 Cytokine-mediated Inflammation by a Soluble CD30 Homologue Encoded by Ectromelia (Mousepox) Virus J. Exp. Med., September 16, 2002; 196(6): 829 - 839. [Abstract] [Full Text] [PDF]

				S. Hay and G. Kannourakis A time to kill: viral manipulation of the cell death program J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564. [Abstract] [Full Text] [PDF]